Search research articles
Contact Us
Filters
Showing results (41-50 of 120) with videos related to
Page
of 12
Sort By:
Best Practice & Research. Clinical Endocrinology & Metabolism
|
December 16, 2018
Parathyroid carcinoma
Antonio Stefano Salcuni, Filomena Cetani, Vito Guarnieri, et al.
European Journal of Endocrinology
|
June 9, 2019
MANAGEMENT OF ENDOCRINE DISEASE: Unmet therapeutic, educational and scientific needs in parathyroid disorders
Jens Bollerslev, Camilla Schalin-Jäntti, Lars Rejnmark, et al.
International Journal of Molecular Sciences
|
February 27, 2026
Effects of Gender, Menopause, Vitamin D Status, and Tumor Parathyroid Cell Activity on Serum Phosphate Levels in a Large Cohort of Patients with Sporadic Hypercalcemic Primary Hyperparathyroidism
Matteo Corbetta, Silvia Carrara, Anna Dal Lago, et al.
The Journal of Clinical Endocrinology and Metabolism
|
November 29, 2020
Do the Heterozygous Carriers of a CYP24A1 Mutation Display a Different Biochemical Phenotype Than Wild Types?
Alessandro Brancatella, Daniele Cappellani, Martin Kaufmann, et al.
The Journal of Clinical Endocrinology and Metabolism
|
March 29, 2021
Pseudohypoparathyroidism: Focus on Cerebral and Renal Calcifications
Laura Mazoni, Matteo Apicella, Federica Saponaro, et al.
Journal of Endocrinological Investigation
|
April 24, 2026
Gender differences in long-term complications of chronic hypoparathyroidism: a systematic review
Filomena Cetani, Laura Pierotti, Ilaria Bodini, et al.
European Journal of Endocrinology
|
November 4, 2021
Hypercalcemia due to CYP24A1 mutations: a systematic descriptive review
Daniele Cappellani, Alessandro Brancatella, Riccardo Morganti, et al.
The Journal of Clinical Endocrinology and Metabolism
|
December 22, 2009
The sulfaphenazole-sensitive pathway acts as a compensatory mechanism for impaired nitric oxide availability in patients with primary hyperparathyroidism. Effect of surgical treatment
Agostino Virdis, Filomena Cetani, Chiara Giannarelli, et al.
Journal of Nephrology
|
May 21, 2004
High doses of intravenous calcitriol in the treatment of severe secondary hyperparathyroidism
Massimo Morosetti, Ljiljana Jankovic, Filomena Cetani, et al.
BMC Cancer
|
December 25, 2012
Functioning glucagonoma associated with primary hyperparathyroidism: multiple endocrine neoplasia type 1 or incidental association?
Enrico Erdas, Nicola Aste, Luca Pilloni, et al.
Page
of 12
Search research articles
Search
Showing results (41-50 of 120) with videos related to
Sort By:
Page
of 12
Best Practice & Research. Clinical Endocrinology & Metabolism
|
December 16, 2018
Parathyroid carcinoma
Antonio Stefano Salcuni, Filomena Cetani, Vito Guarnieri, et al.
European Journal of Endocrinology
|
June 9, 2019
MANAGEMENT OF ENDOCRINE DISEASE: Unmet therapeutic, educational and scientific needs in parathyroid disorders
Jens Bollerslev, Camilla Schalin-Jäntti, Lars Rejnmark, et al.
International Journal of Molecular Sciences
|
February 27, 2026
Effects of Gender, Menopause, Vitamin D Status, and Tumor Parathyroid Cell Activity on Serum Phosphate Levels in a Large Cohort of Patients with Sporadic Hypercalcemic Primary Hyperparathyroidism
Matteo Corbetta, Silvia Carrara, Anna Dal Lago, et al.
The Journal of Clinical Endocrinology and Metabolism
|
November 29, 2020
Do the Heterozygous Carriers of a CYP24A1 Mutation Display a Different Biochemical Phenotype Than Wild Types?
Alessandro Brancatella, Daniele Cappellani, Martin Kaufmann, et al.
The Journal of Clinical Endocrinology and Metabolism
|
March 29, 2021
Pseudohypoparathyroidism: Focus on Cerebral and Renal Calcifications
Laura Mazoni, Matteo Apicella, Federica Saponaro, et al.
Journal of Endocrinological Investigation
|
April 24, 2026
Gender differences in long-term complications of chronic hypoparathyroidism: a systematic review
Filomena Cetani, Laura Pierotti, Ilaria Bodini, et al.
European Journal of Endocrinology
|
November 4, 2021
Hypercalcemia due to CYP24A1 mutations: a systematic descriptive review
Daniele Cappellani, Alessandro Brancatella, Riccardo Morganti, et al.
The Journal of Clinical Endocrinology and Metabolism
|
December 22, 2009
The sulfaphenazole-sensitive pathway acts as a compensatory mechanism for impaired nitric oxide availability in patients with primary hyperparathyroidism. Effect of surgical treatment
Agostino Virdis, Filomena Cetani, Chiara Giannarelli, et al.
Journal of Nephrology
|
May 21, 2004
High doses of intravenous calcitriol in the treatment of severe secondary hyperparathyroidism
Massimo Morosetti, Ljiljana Jankovic, Filomena Cetani, et al.
BMC Cancer
|
December 25, 2012
Functioning glucagonoma associated with primary hyperparathyroidism: multiple endocrine neoplasia type 1 or incidental association?
Enrico Erdas, Nicola Aste, Luca Pilloni, et al.
Page
of 12